XFOR
X4 Pharmaceuticals Inc
3.00$
+0.2%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -14.3% | +0.0% | -100.0% | – | – | – | +1,273.2% | |
| – | -25.0% | -35.0% | -47.2% | +552.4% | +83.0% | +53.8% | +5.4% | +0.1% | -60.1% | +685.1% | |
| – | – | – | – | – | – | -163.1% | – | – | – | +1,539.5% | |
| – | +40.3% | +57.7% | -27.7% | +48.3% | +39.0% | +16.3% | +25.2% | +17.9% | +13.4% | -11.5% | |
| – | +207.5% | +22.9% | +129.9% | -4.2% | +18.7% | +18.0% | +9.4% | +19.0% | +91.4% | -29.3% | |
| – | +66.7% | +49.5% | -19.4% | +59.2% | +36.3% | +16.8% | +19.2% | +22.8% | -64.5% | +203.3% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | +432.8% | -17.3% | -65.4% | +198.2% | +25.2% | +35.5% | +9.6% | +44.7% | +51.8% | +1.2% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | +563.0% | -28.7% | +108.9% | -2.7% | -96.1% | -88.5% | +64.7% | +178.6% | +297.4% | -86.8% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.